MEDICAMEN BIOTECH
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Medicamen Biotech along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.72₹ -2.45
As on Sep 16, 2025, 2:29 PM IST
Medicamen Biotech Price Performance
Today's LowToday's High
₹339.00₹348.25
₹339.00
52 Weeks' Low52 Weeks' High
₹339.05₹630.00
₹339.00
Open Price
₹340.60
Prev. Close
₹341.45
Volume
1,857
Over the last 5 years, the share price of Medicamen Biotech has declined 3.33% CAGR. Over the past year, the corresponding return has been -29.15%.
Medicamen Biotech’s current P/E of 51.55x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Medicamen Biotech Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Medicamen Biotech | -0.96 | -4.14 | -16.87 | -17.15 | -28.94 | -31.40 | -3.27 |
| Sun Pharmaceutical Industries | 0.68 | -1.62 | -4.72 | -5.87 | -13.80 | 22.73 | 25.36 |
| Divi's Laboratories | 1.18 | -1.55 | -9.24 | 7.08 | 10.80 | 19.32 | 13.35 |
| Cipla | 0.27 | -0.54 | 1.91 | 4.22 | -6.25 | 14.18 | 15.63 |
| Torrent Pharmaceuticals | -2.85 | -3.14 | 7.93 | 15.63 | 2.49 | 33.80 | 19.99 |
| Dr. Reddy's Laboratories | 0.98 | 3.35 | -3.01 | 13.53 | -1.77 | 16.96 | 7.11 |
| Mankind Pharma | -0.64 | 4.17 | 8.66 | 18.46 | 4.75 | 21.80 | 12.56 |
| Zydus Lifesciences | -0.06 | 5.02 | 6.37 | 15.98 | -7.13 | 42.16 | 21.68 |
| Lupin | 4.41 | 3.86 | 1.73 | 2.73 | -9.18 | 47.91 | 14.74 |
| Abbott India | 1.33 | -4.84 | -1.92 | 2.91 | 6.55 | 20.94 | 13.43 |
| Alkem Laboratories | 2.85 | 2.51 | 12.66 | 13.84 | -13.75 | 19.82 | 14.18 |
| Aurobindo Pharma | 4.88 | 0.46 | -4.27 | -1.60 | -29.90 | 27.07 | 5.66 |
| Glenmark Pharmaceuticals | -1.70 | 5.37 | 23.64 | 45.38 | 19.43 | 77.42 | 33.00 |
| Laurus Labs | -0.78 | 3.45 | 31.67 | 53.96 | 77.43 | 20.10 | 27.14 |
| Biocon | -1.28 | -1.15 | 0.76 | 7.82 | -7.87 | 7.34 | -3.86 |
| Anthem Biosciences | 2.55 | 4.88 | 14.99 | 14.99 | 14.99 | 4.76 | 2.83 |
| GlaxoSmithKline Pharmaceuticals | -2.21 | -1.20 | -18.13 | 2.36 | -2.61 | 24.40 | 9.25 |
| Cohance Lifesciences | -3.39 | 9.53 | -0.95 | -13.30 | -15.96 | 28.74 | 21.40 |
| Gland Pharma | 6.54 | 3.71 | 15.59 | 31.65 | 9.61 | -3.74 | 2.35 |
| Ipca Laboratories | -0.98 | -5.67 | -4.11 | -0.71 | -10.48 | 14.83 | 3.44 |
Over the last one year, Medicamen Biotech has declined 28.94% compared to peers like Sun Pharmaceutical Industries (-13.80%), Divi's Laboratories (10.80%), Cipla (-6.25%). From a 5 year perspective, Medicamen Biotech has underperformed peers relative to Sun Pharmaceutical Industries (25.36%) and Divi's Laboratories (13.35%).
Medicamen Biotech Financials
Medicamen Biotech Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 347.78 | 346.61 |
| 10 | 347.88 | 347.88 |
| 20 | 350.05 | 352.52 |
| 50 | 373.77 | 370.76 |
| 100 | 401.22 | 396.07 |
| 200 | 446.92 | 428.53 |
Medicamen Biotech Share Holding Pattern
In the latest quarter, Medicamen Biotech remained same as its previous close in promoter holding, while DII stake decreased to 0.64%, FII holding fell to 0.00%, and public shareholding moved up to 58.83% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Medicamen Biotech Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 04, 2025, 10:45 PM IST | Medicamen Biotec - Revised Intimation Of Book Closure In Accordance With Regulation 42 Of The SEBI (Listing Obligations And D |
| Sep 04, 2025, 5:08 PM IST | Medicamen Biotec - Intimation Of Book Closure In Accordance With Regulation 42 Of The SEBI (Listing Obligations And Disclosur |
| Sep 03, 2025, 11:58 PM IST | Medicamen Biotec - Reg. 34 (1) Annual Report. |
| Aug 13, 2025, 12:07 AM IST | Medicamen Biotec - Announcement under Regulation 30 (LODR)-Change in Management |
| Aug 13, 2025, 12:04 AM IST | Medicamen Biotec - Business Responsibility and Sustainability Reporting (BRSR) |
About Medicamen Biotech
Medicamen Biotech Ltd. is a Public Limited Listed company incorporated on 22/12/1993 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1993PLC056594 and registration number is 056594. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 151.46 Cr. and Equity Capital is Rs. 12.71 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address1506, Chiranjiv Tower, 43, Nehru Place, New Delhi Delhi 110019
- Contact
Management
- Mr. Rahul BishnoiChairman
- Mr. Ashwani Kumar SharmaNon Executive Director
- Dr. Vimal Kumar ShrawatNon Executive Director
- Mr. Sanjay BansalNon Executive Director
- Mr. Suresh Kumar SinghNon Executive Director
- Mr. Arun KumarIndependent Director
- Mr. Harish PandeIndependent Director
- Ms. Sangeeta BishnoiIndependent Director
- Dr. Ravi Kumar BansalIndependent Director
- Mrs. Sumita DwivediIndependent Director
FAQs on Medicamen Biotech Share Price
What is the share price of Medicamen Biotech?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Medicamen Biotech is ₹339.00 as on Sep 16, 2025.
What kind of stock is Medicamen Biotech?
The Medicamen Biotech is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Medicamen Biotech?
The market cap of Medicamen Biotech is ₹461.20 Cr as on Sep 16, 2025.
What are today's High and Low prices of Medicamen Biotech?
Today’s highest and lowest price of Medicamen Biotech are ₹348.25 and ₹339.00.
What are the 52 Week High and 52 Week Low of Medicamen Biotech?
The 52-week high/low is the highest and lowest price at which Medicamen Biotech stock has traded in the past 52-week or nearly a year. The 52-week high of Medicamen Biotech is ₹630.00 and 52-week low of Medicamen Biotech is ₹339.05 as on Sep 16, 2025.
How has the Medicamen Biotech performed historically in terms of returns?
The Medicamen Biotech has shown returns of -0.72% over the past day, -4.43% for the past month, -17.11% over 3 months, -29.15% over 1 year, -31.47% across 3 years, and -3.33% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Medicamen Biotech?
P/E ratio of and PB ratio of Medicamen Biotech are 51.55 and 2.13 on Sep 16, 2025. While the company gives a dividend yield of 0.29 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data